Florence Gaven

1.9k total citations
25 papers, 1.5k citations indexed

About

Florence Gaven is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Florence Gaven has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Florence Gaven's work include Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Florence Gaven is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Florence Gaven collaborates with scholars based in France, United States and Germany. Florence Gaven's co-authors include Joël Bockaert, Sylvie Claeysen, Philippe Marin, Aline Dumuis, Jean‐Philippe Pin, Sylvia Pietri, Marcel Culcasi, Mireille Lafon‐Cazal, Francine Acher and Gaël Barthet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Florence Gaven

24 papers receiving 1.5k citations

Peers

Florence Gaven

CMN

PHARM

PHYSI

CTM

Margaret M. Racke United States

José Á. Morales-García Spain

Herman Devijver Belgium

Lit‐Fui Lau United States

Michael Rigby United Kingdom

Daniel H. S. Lee United States

Núria Durany Spain

Vladimı́r Doležal Czechia

Laurent Lecanu United States

Jan Říčný Czechia

Margaret M. Racke United States

Florence Gaven

832 ×1.0

CMN

815 ×1.0

260 ×0.8

PHARM

693 ×2.2

PHYSI

155 ×0.8

CTM

Citations per year, relative to Florence Gaven Florence Gaven (= 1×) peers Margaret M. Racke

Countries citing papers authored by Florence Gaven

Since Specialization

Citations

This map shows the geographic impact of Florence Gaven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Gaven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Gaven more than expected).

Fields of papers citing papers by Florence Gaven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Gaven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Gaven. The network helps show where Florence Gaven may publish in the future.

Co-authorship network of co-authors of Florence Gaven

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Gaven. A scholar is included among the top collaborators of Florence Gaven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Gaven. Florence Gaven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rochais, Christophe, Cédric Lecoutey, Audrey Davis, et al.. (2024). Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 280. 116975–116975.

Rochais, Christophe, Cédric Lecoutey, Patrizia Giannoni, et al.. (2019). Donecopride, a Swiss army knife with potential against Alzheimer's disease. British Journal of Pharmacology. 177(9). 1988–2005. 27 indexed citations

Baranger, Kévin, Patrizia Giannoni, Stéphane D. Girard, et al.. (2017). Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology. 126. 128–141. 48 indexed citations

Gaven, Florence, Philippe Marin, & Sylvie Claeysen. (2014). Primary Culture of Mouse Dopaminergic Neurons. Journal of Visualized Experiments. e51751–e51751. 53 indexed citations

Gaven, Florence, Philippe Marin, & Sylvie Claeysen. (2014). Primary Culture of Mouse Dopaminergic Neurons. Journal of Visualized Experiments. 21 indexed citations

Giannoni, Patrizia, Florence Gaven, Dimitri De Bundel, et al.. (2013). Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease. Frontiers in Aging Neuroscience. 5. 96–96. 75 indexed citations

Claeysen, Sylvie, et al.. (2013). Serotonin Type 4 Receptor Dimers. Methods in cell biology. 117. 123–139. 1 indexed citations

Alcacer, Cristina, Emanuela Santini, Emmanuel Valjent, et al.. (2012). Gα_olfMutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia. Journal of Neuroscience. 32(17). 5900–5910. 73 indexed citations

Gaven, Florence, et al.. (2012). Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands. Brain Research. 1511. 65–72. 6 indexed citations

10.

Meffre, Julie, Séverine Chaumont‐Dubel, Clotilde Mannoury la Cour, et al.. (2012). 5‐HT ₆ receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Molecular Medicine. 4(10). 1043–1056. 134 indexed citations

11.

Pellissier, Lucie P., Gaël Barthet, Florence Gaven, et al.. (2011). G Protein Activation by Serotonin Type 4 Receptor Dimers. Journal of Biological Chemistry. 286(12). 9985–9997. 61 indexed citations

12.

Barthet, Gaël, Gaëlle Carrat, Florence Gaven, et al.. (2009). β‐arrestin1 phosphorylation by GRK5 regulates G protein‐independent 5‐HT4 receptor signalling. The EMBO Journal. 28(18). 2706–2718. 60 indexed citations

13.

Pellissier, Lucie P., Jessica Sallander, Mercedes Campillo, et al.. (2009). Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors. Molecular Pharmacology. 75(4). 982–990. 52 indexed citations

14.

Barthet, Gaël, Florence Gaven, Lucie P. Pellissier, et al.. (2007). 5-Hydroxytryptamine₄Receptor Activation of the Extracellular Signal-regulated Kinase Pathway Depends on Src Activation but Not on G Protein or β-Arrestin Signaling. Molecular Biology of the Cell. 18(6). 1979–1991. 66 indexed citations

15.

Ponimaskin, Evgeni, Aline Dumuis, Florence Gaven, et al.. (2005). Palmitoylation of the 5-Hydroxytryptamine4a Receptor Regulates Receptor Phosphorylation, Desensitization, and β-Arrestin-Mediated Endocytosis. Molecular Pharmacology. 67(5). 1434–1443. 45 indexed citations

16.

Barthet, Gaël, Florence Gaven, Katsuhiro Shinjo, et al.. (2005). Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors. Journal of Biological Chemistry. 280(30). 27924–27934. 46 indexed citations

17.

Dechesne, Claude J., Pierre G. Milhaud, Danielle Demêmes, et al.. (2003). Confinement but not microgravity alters NMDA NR1 receptor expression in rat inner ear ganglia. Neuroreport. 14(6). 887–890. 2 indexed citations

18.

Bessis, Anne‐Sophie, Philippe Rondard, Florence Gaven, et al.. (2002). Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists. Proceedings of the National Academy of Sciences. 99(17). 11097–11102. 85 indexed citations

19.

Dechesne, Claude J., et al.. (2001). Development of the rat efferent vestibular system on the ground and in microgravity. Developmental Brain Research. 128(1). 35–44. 33 indexed citations

20.

Lafon‐Cazal, Mireille, Marcel Culcasi, Florence Gaven, Sylvia Pietri, & Joël Bockaert. (1993). Nitric oxide, superoxide and peroxynitrite: Putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology. 32(11). 1259–1266. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact